CC(=O)Oc1ccc2c(c1)CC[C@@H]1C2[C@@H](O[N+](=O)[O-])C[C@@]2(C)C1CC[C@@H]2O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?